Older adults are the main consumers of drugs but are rarely included in pivotal RCTs. Hence, pharmacoepidemiology is central to understanding drug safety in elderly patients. The mission of the Geriatric pharmacoepidemiology Special Interest Group is therefore to provide a collaborative forum to discuss, develop, and improve the methods, applications, and dissemination of geriatric pharmacoepidemiology.
- To create a forum for discussing the challenges and endeavours of geriatric pharmacoepidemiology
- To discuss, develop and propose high-quality standards for geriatric pharmacoepidemiology research
- To develop, test, and validate best methods for drug safety research in geriatric populations
- To promote the geriatric perspective by outreach, collaboration and educational activities.